Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|15|4|361-373
ISSN: 1389-4501
Source: Current Drug Targets, Vol.15, Iss.4, 2014-04, pp. : 361-373
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Small non-coding microRNAs (miRNAs) regulate gene expression at the post-transcriptional and translational levels. The dysregulated miRNAs are involved in a large variety of diseases including cancer and cardiovascular diseases. MiR-34a is one of the most anti-oncomiRs that is down-regulated in multiple types of cancer. It regulates a wide range of genes and pathways involved in cancer initiation, progression and metastasis. Next to cancer, miR-34a is recently found to be implicated in cardiovascular disease as one damager factor. In this review, we highlight the complex roles of miR-34a in cancer and cardiovascular disease, as well as the therapeutic potentials.
Related content
MicroRNA-21: From Cancer to Cardiovascular Disease
Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. :
MicroRNA Regulation in Cardiovascular Disease
Current Drug Targets, Vol. 11, Iss. 8, 2010-08 ,pp. :
microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets, Vol. 11, Iss. 8, 2010-08 ,pp. :
MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Current Cancer Drug Targets, Vol. 14, Iss. 8, 2014-10 ,pp. :